Rogco LP’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$611K Sell
7,054
-30
-0.4% -$2.87K 0.2% 71
2025
Q4
$680K Buy
7,084
+41
+0.6% +$3.98K 0.23% 67
2025
Q3
$671K Buy
7,043
+208
+3% +$19.1K 0.24% 67
2025
Q2
$596K Buy
6,835
+660
+11% +$56K 0.22% 72
2025
Q1
$555K Sell
6,175
-458
-7% -$41K 0.22% 71
2024
Q4
$530K Buy
6,633
+61
+0.9% +$5.28K 0.22% 74
2024
Q3
$592K Sell
6,572
-481
-7% -$40.5K 0.23% 72
2024
Q2
$555K Buy
7,053
+291
+4% +$23.9K 0.23% 69
2024
Q1
$589K Sell
6,762
-52
-0.8% -$4.44K 0.24% 69
2023
Q4
$561K Buy
6,814
+129
+2% +$9.83K 0.25% 63
2023
Q3
$524K Buy
+6,685
New +$560K 0.26% 59

Other funds holding MDT

Rogco LP's MDT Position: Q1 2026 in Review

Rogco LP reduced its Medtronic (MDT) stake by 0.42% in Q1 2026, selling an estimated $2.87K and leaving 7,054 shares worth $611K. The position accounts for 0.2% of the portfolio, ranked #71.

Rogco LP first reported a position in MDT in Q3 2023 and has held it in 11 quarters since. The position peaked at $680K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Rogco LP held 7,054 shares of Medtronic worth $611K as of Q1 2026.
  • Rogco LP sold 30 Medtronic shares in Q1 2026, an estimated $2.87K.
  • Medtronic made up 0.2% of Rogco LP's portfolio in Q1 2026, its #71 holding.
  • Rogco LP first reported a position in Medtronic in Q3 2023 and has held it in 11 quarters since.
  • Rogco LP's Medtronic position peaked at $680K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Rogco LP's 13F filing for Q1 2026, filed 5 May 2026.